Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 4A4BM | IM / RA |
Patient developed rash around injection site. Also developed rash on the leg which patient states was sensitive to the touch. 1 week post injection patient reports that rash is less sensitive to the touch and improving. Patient stated that she spoke with her provider who was supposed to prescribe a topical treatment. It is unknown if patient received treatment.
Estradiol vaginal insert, TRETINOIN topical cream
sulfa drugs